182 related articles for article (PubMed ID: 34079245)
21. [Correlation between expressions of myeloperoxidase and eosinophil cationic protein in sputum and clinical features of asthma-chronic obstructive pulmonary disease overlap].
Yang H; Zhang Y; Zhang J; Pan J; Wang F; Luo X; Chen F
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1215-1221. PubMed ID: 30377121
[TBL] [Abstract][Full Text] [Related]
22. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R
COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
[TBL] [Abstract][Full Text] [Related]
23. Dynamic differences in dietary polyunsaturated fatty acid metabolism in sputum of COPD patients and controls.
van der Does AM; Heijink M; Mayboroda OA; Persson LJ; Aanerud M; Bakke P; Eagan TM; Hiemstra PS; Giera M
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Mar; 1864(3):224-233. PubMed ID: 30528790
[TBL] [Abstract][Full Text] [Related]
24. Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease.
Zeiger RS; Tran TN; Butler RK; Schatz M; Li Q; Khatry DB; Martin U; Kawatkar AA; Chen W
J Allergy Clin Immunol Pract; 2018; 6(3):944-954.e5. PubMed ID: 29153881
[TBL] [Abstract][Full Text] [Related]
25. Eosinophilic Airway Inflammation in Patients with Stable Biomass Smoke- versus Tobacco Smoke-Associated Chronic Obstructive Pulmonary Disease.
Fernandes L; Rane S; Mandrekar S; Mesquita AM
J Health Pollut; 2019 Dec; 9(24):191209. PubMed ID: 31893170
[TBL] [Abstract][Full Text] [Related]
26. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
27. Eosinophil Inflammation and Hyperresponsiveness in the Airways as Phenotypes of COPD, and Usefulness of Inhaled Glucocorticosteroids.
Kume H; Hojo M; Hashimoto N
Front Pharmacol; 2019; 10():765. PubMed ID: 31404293
[No Abstract] [Full Text] [Related]
28. Increased prostaglandin E2 concentrations and cyclooxygenase-2 expression in asthmatic subjects with sputum eosinophilia.
Profita M; Sala A; Bonanno A; Riccobono L; Siena L; Melis MR; Di Giorgi R; Mirabella F; Gjomarkaj M; Bonsignore G; Vignola AM
J Allergy Clin Immunol; 2003 Oct; 112(4):709-16. PubMed ID: 14564348
[TBL] [Abstract][Full Text] [Related]
29. COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils.
Eltboli O; Bafadhel M; Hollins F; Wright A; Hargadon B; Kulkarni N; Brightling C
BMC Pulm Med; 2014 Jul; 14():112. PubMed ID: 25007795
[TBL] [Abstract][Full Text] [Related]
30. Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients.
Pignatti P; Visca D; Cherubino F; Zampogna E; Lucini E; Saderi L; Sotgiu G; Spanevello A
Respir Res; 2019 Jul; 20(1):145. PubMed ID: 31291952
[TBL] [Abstract][Full Text] [Related]
31. Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD.
Bafadhel M; Saha S; Siva R; McCormick M; Monteiro W; Rugman P; Dodson P; Pavord ID; Newbold P; Brightling CE
Respiration; 2009; 78(3):256-62. PubMed ID: 19478474
[TBL] [Abstract][Full Text] [Related]
32. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.
Foschino Barbaro MP; Carpagnano GE; Spanevello A; Cagnazzo MG; Barnes PJ
Int J Immunopathol Pharmacol; 2007; 20(4):753-63. PubMed ID: 18179748
[TBL] [Abstract][Full Text] [Related]
33. Induced sputum eicosanoid concentrations in asthma.
Pavord ID; Ward R; Woltmann G; Wardlaw AJ; Sheller JR; Dworski R
Am J Respir Crit Care Med; 1999 Dec; 160(6):1905-9. PubMed ID: 10588604
[TBL] [Abstract][Full Text] [Related]
34. Eosinophilic inflammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway function.
Balzano G; Stefanelli F; Iorio C; De Felice A; Melillo EM; Martucci M; Melillo G
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1486-92. PubMed ID: 10556110
[TBL] [Abstract][Full Text] [Related]
35. Subphenotypes of nonsteroidal antiinflammatory disease-exacerbated respiratory disease identified by latent class analysis.
Celejewska-Wójcik N; Wójcik K; Ignacak-Popiel M; Ćmiel A; Tyrak K; Gielicz A; Kania A; Nastałek P; Sanak M; Mastalerz L
Allergy; 2020 Apr; 75(4):831-840. PubMed ID: 31803947
[TBL] [Abstract][Full Text] [Related]
36. Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD.
Zhu J; Mallia P; Footitt J; Qiu Y; Message SD; Kebadze T; Aniscenko J; Barnes PJ; Adcock IM; Kon OM; Johnson M; Contoli M; Stanciu LA; Papi A; Jeffery PK; Johnston SL
J Allergy Clin Immunol; 2020 Oct; 146(4):840-850.e7. PubMed ID: 32283204
[TBL] [Abstract][Full Text] [Related]
37. Airway inflammation in COPD assessed by sputum levels of interleukin-8.
Yamamoto C; Yoneda T; Yoshikawa M; Fu A; Tokuyama T; Tsukaguchi K; Narita N
Chest; 1997 Aug; 112(2):505-10. PubMed ID: 9266891
[TBL] [Abstract][Full Text] [Related]
38. Exhaled Hydrogen Sulfide Predicts Airway Inflammation Phenotype in COPD.
Zhang J; Wang X; Chen Y; Yao W
Respir Care; 2015 Feb; 60(2):251-8. PubMed ID: 25336529
[TBL] [Abstract][Full Text] [Related]
39. Disease burden of eosinophilic airway disease: Comparing severe asthma, COPD and asthma-COPD overlap.
Hiles SA; Gibson PG; McDonald VM
Respirology; 2021 Jan; 26(1):52-61. PubMed ID: 32428971
[TBL] [Abstract][Full Text] [Related]
40. Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma.
Brightling CE; Ward R; Woltmann G; Bradding P; Sheller JR; Dworski R; Pavord ID
Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):878-82. PubMed ID: 10988099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
